Related Experiment Video
Updated: Jul 15, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart
Elina Minami1, Michael A Laflamme, Jeffrey E Saffitz
1Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Insights
Extracardiac progenitor cells repopulate heart cells after transplantation, with endothelial cells showing the highest integration. This early and extensive endothelial chimerism may impact graft health and rejection.
Area of Science:
- Cardiovascular Biology
- Transplantation Immunology
- Stem Cell Biology
Background:
- Extracardiac progenitor cells can integrate into the heart post-injury, but their extent in human heart transplants is unclear.
- Previous studies showed limited cardiomyocyte repopulation by these cells.
Purpose of the Study:
- To investigate the degree of endothelial, smooth muscle, and Schwann cell chimerism in human heart transplants.
- To compare chimerism levels across different cell types and vessel sizes.
Main Methods:
- Analysis of autopsy and endomyocardial biopsy specimens from heart transplant recipients.
- Immunohistochemistry for endothelial (CD31), smooth muscle (alpha-actin), and Schwann (S-100) cells.
- Y chromosome in situ hybridization to identify donor-derived cells in sex-mismatched transplants.
Main Results:
- Endothelial cells exhibited the highest extracardiac chimerism (24.3%), followed by Schwann cells (11.2%) and vascular smooth muscle cells (3.4%).
- Chimerism levels were significantly higher than previously observed for cardiomyocytes (0.04%).
- High endothelial chimerism was detected as early as 1 month post-transplant and persisted up to 10 years, with greater prevalence in microcirculation.
Conclusions:
- Extracardiac progenitor cells repopulate various heart cell types with differing frequencies.
- Early recruitment of endothelial progenitors suggests a role for transplantation-related injury.
- High endothelial chimerism may influence myocardial rejection and graft vasculopathy.
Background:
Extracardiac progenitor cells are capable of repopulating cardiomyocytes at very low levels in the human heart after injury. Here, we explored the extent of endothelial, smooth muscle, and Schwann cell chimerism in patients with sex-mismatched (female-to-male) heart transplants.
Methods And Results:
Autopsy specimens from 5 patients and endomyocardial biopsies from 7 patients were used for this study. Endothelial, vascular smooth muscle, and Schwann cells were stained with antibodies against CD31 or Ulex europaeus lectin, smooth muscle alpha-actin, and S-100, respectively, and the Y chromosome was identified with in situ hybridization. Biopsy specimens from 1, 4, 6, and 12 months and 5 and 10 years after heart transplantation were evaluated. Y-positive cells were counted by conventional bright-field microscopy and confirmed by confocal microscopy. Endothelial cells showed the highest degree of chimerism, averaging 24.3+/-8.2% from extracardiac sources. Schwann cells showed the next highest chimerism, averaging 11.2+/-2.1%; vascular smooth muscle cells averaged 3.4+/-1.8%. All 3 cell types showed substantially higher chimerism than we previously observed for cardiomyocytes (0.04+/-0.05%). Endothelial chimerism was much higher in the microcirculation than in larger vessels. Analysis of serial endomyocardial biopsies revealed that high levels of endothelial chimerism occurred as early as 1 month after transplantation (22+/-6.6%) with no significant increases even up to 10 years after cardiac transplantation.
Conclusions:
Extracardiac progenitor cells are capable of repopulating most major cell types in the heart, but they do so with varying frequency. The signals for endothelial progenitor recruitment occur early and could relate to injury during allograft harvest or transplantation. The high degree of endothelial chimerism may have immune implications such as for myocardial rejection or graft vasculopathy.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation

